Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy-论文-万方医学网

Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy

导出原文传递

翻译打印收藏纠错

作者： Pece, Salvatore ^[1] ; Sestak, Ivana ^[2] ; Montani, Francesca ^[3] ; Tillhon, Micol ; Maisonneuve, Patrick ; Freddi, Stefano ; Chu, Kim ; Colleoni, Marco ; Veronesi, Paolo ; Disalvatore, Davide ; Viale, Giuseppe ; Buus, Richard ; Cuzick, Jack ; Dowsett, Mitch ; Di Fiore, Pier Paolo

作者单位： IEO,Ist Europe Oncol IRCCS ^[1] Ctr Canc Prevent,Queen Mary Univ London ^[2] Breast Canc Now Toby Robins Res Ctr,Inst Canc Res ^[3]

关键词 Breast cancer Prognostic genomic tools Cancer stem cells Biomarkers Metastasis INTERNATIONAL EXPERT CONSENSUS ESTROGEN-RECEPTOR ADJUVANT THERAPY TAMOXIFEN WOMEN ANASTROZOLE VALIDATION DECISIONS ASSAY

发布时间 2022-08-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy

相似文献

相关期刊

检索历史清除